HawaiiSCR 82025–2026 Regular Session (Year 1)Senate

REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

Sponsored By: Kurt Fevella (Republican)

In Committee

HealthMedicaidInsuranceKetamine TherapyAuditorReportHLT, FIN

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Kurt Fevella

    Republican • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 11 • No: 0

House vote • 4/11/2025

The committee on HLT recommend that the measure be PASSED, UNAMENDED. The votes ...

Yes: 7 • No: 0

Senate vote • 3/24/2025

The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENT...

Yes: 4 • No: 0

Actions Timeline

  1. Reported from HLT (Stand. Com. Rep. No. 2071), recommending referral to FIN.

    4/14/2025House
  2. Report adopted; referred to the committee(s) on FIN with none voting aye with reservations; none voting no (0) and none excused (0).

    4/14/2025House
  3. The committee on HLT recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 7 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Chun, Marten, Olds, Alcos; Ayes with reservations: none; Noes: none; and 2 Excused: Representative(s) Takenouchi, Garcia.

    4/11/2025House
  4. Resolution scheduled to be heard by HLT on Friday, 04-11-25 10:00AM in conference room 329 VIA VIDEOCONFERENCE.

    4/8/2025House
  5. Referred to HLT, FIN, referral sheet 28

    4/4/2025House
  6. Resolution Adopted as amended (SD1). Aye(s) with reservations: Senator(s) McKelvey. Noes, 0 (none). Transmitted to House.

    3/31/2025Senate
  7. Received from Senate (Sen. Com. No. 415) in amended form (SD 1).

    3/31/2025House
  8. Waived referral to WAM.

    3/28/2025Senate
  9. One Day Notice 03-31-25

    3/28/2025Senate
  10. The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Keohokalole; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.

    3/24/2025Senate
  11. Reported from HHS (Stand. Com. Rep. No. 1360), as amended (SD 1), with recommendation of referral to WAM.

    3/24/2025Senate
  12. Report adopted, as amended (SD 1) and referred to WAM.

    3/24/2025Senate
  13. The committee(s) on HHS has scheduled a public hearing on 03-24-25 1:05PM; Conference Room 225 & Videoconference.

    3/20/2025Senate
  14. Referred to HHS, WAM.

    2/3/2025Senate
  15. Offered.

    1/30/2025Senate

Bill Text

Related Bills

Back to State Legislation